zBMI long term (> 15 months) · children aged 5 to 11 years
1 finding from 1 review
Serious adverse events · children aged 5 to 11 years
1 finding from 1 review
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 12 to 18 years
3 findings from 1 review
no estimate extracted
3 studies · 605 participants
Very low
no estimate extracted
3 studies · 900 participants
Very low
no estimate extracted
1 study · 44 participants
Low
Body‐mass index (BMI) · children aged 12 to 18 years
3 findings from 1 review
no estimate extracted
1 study · 985 participants
Low
no estimate extracted
6 studies · 1780 participants
Low
no estimate extracted
3 studies · 2143 participants
Low
zBMI short term (12 weeks from baseline to < 9 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 12 to 18 years
1 finding from 1 review
Serious adverse events · children aged 12 to 18 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 12 to 18 years
3 findings from 1 review
no estimate extracted
11 studies · 3429 participants
High
no estimate extracted
8 studies · 5612 participants
Moderate
no estimate extracted
6 studies · 8736 participants
Moderate
zBMI short term (12 weeks from baseline to < 9 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 12 to 18 years
1 finding from 1 review
Serious adverse events · children aged 12 to 18 years
1 finding from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 12 to 18 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 12 to 18 years
1 finding from 1 review
Serious adverse events · children aged 12 to 18 years
1 finding from 1 review
Mental state · recent‐onset psychosis (less than three years since the start of psychotic symptoms and either first or second psychotic episode)
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (combined time points) · recent‐onset psychosis (less than three years since the start of psychotic symptoms and either first or second psychotic episode)
Summary of findings table ‐ Cognitive behavioural therapy plus… showed no clear difference in global state ‐ number of participants with relapse/exacerbations of… compared with control (low certainty).
1 finding from 1 review